Skip to main content

Table 1 Parameter values for Schistosoma haematobium used in making model predictions of MDA impact (some directly estimated from age-intensity or prevalence profiles and some derived from the literature).

From: The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?

Parameter

Value

Source

Population size

500

–

Fecundity

3.6 eggs/female/sample

[26, 27]

Transmission intensity

R0 = 2.5

Fitted

Level of aggregation of parasites in host population

Negative binomial, k = 0.24

[28]

Adult worm life expectancy

4 years

[16, 17]

Praziquantel drug efficacy

99%

[27, 29]

Age specific contact rates (\({\varvec{\beta}}\)) for the first dataset [25]

For 0–4, 5–11,12–20, 21+ years of age: 0.17, 1, 0.11, 0.035

Fitted

Contribution to the reservoir by contact age group (\({\varvec{\rho}}\)) for the first dataset [25]

For 0–4, 5–11,12–20, 21+ years of age: 0.17, 1, 0.11, 0.035

Fitted

Age specific contact rates (\({\varvec{\beta}}\)) for the second dataset [18]

For 0–4, 5–11, 12+ years of age: 0.0035, 1, 0.0037

Fitted

Contribution to the reservoir by contact age group (\({\varvec{\rho}}\)) for the second dataset [18]

For 0–4, 5–11, 12+ years of age: 0.0035, 1, 0.0037

Fitted

Prevalence of infection

Percentage of population having > 0 eggs/10 ml

–

Heavy-intensity infection prevalence

Percentage of population having ≥ 50 eggs/10 ml

[2, 30]

Human demography

Based on Kenya’s demographic profile

–